Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Biomaterials

Topics

Chemistry

Materials Science

Medicine

Immunology

Physical Chemistry

Show all topics

DOI

10.1016/j.biomaterials.2019.05.012